Meeting on the Med 2021 | Educating patients in cell and gene therapies

Durhane Wong-Rieger, PhD, Rare Disease International, Toronto, ON, discusses increasing patient involvement in the advanced therapies sector. While the field holds great promise, the fact that the development and regulatory approval of novel therapies can take many years has led to impatience and confusion within the patient community. Dr Wong-Rieger highlights the importance of improving patient education on the different types of gene therapy and calls for greater patient involvement in the development process. This interview took place during the Cell & Gene Meeting on the Mediterranean 2021 virtual conference.